The Asia-Pacific (APAC) region is emerging as a pivotal contributor to the global central nervous system (CNS) trials ecosystem. Driven by increased investments from global pharmaceutical companies, APAC has demonstrated significant regional growth with estimates suggesting a compound annual growth rate of around eight to 10 percent across the next few years.
Success in this diverse and rapidly evolving market hinges on overcoming many challenges including standardization, cultural differences, localization, rater identification & training, technology, data accuracy and more.
In this webinar, CNS trial experts from Cogstate — including those native to the region — will delve into the complexities of conducting CNS trials in APAC, focusing on the delicate balance between achieving standardized, high-quality data collection and minimizing cultural bias through consideration of local cultural-linguistic nuances.
Panelists will explore the rising demand for CNS studies in APAC and key factors that drive the region’s appeal for clinical trial teams. The session will focus on addressing regional challenges in CNS endpoint assessment, rater training & monitoring, decentralized trial methodologies and operational considerations and provide practical solutions to overcome hurdles and support high quality data capture in trials with an APAC footprint. Specific case examples from Japan and China will be presented.
Join this webinar to gain a deeper understanding of successfully executing CNS trials in the dynamic APAC region.
Speakers
Svenja Wacker, PhD, Science Director, Business Development, Cogstate
Svenja Wacker, PhD is a bilingual (German/English), licensed clinical neuropsychologist with expertise in global clinical trial management and consultation, as well as extensive experience in hospital-based rehabilitation neuropsychology, neuropsychological assessment and intervention, program development and medical staff training. She serves as Science Director on Cogstate’s Business Development team.
Message Presenter
Mikako Moriyasu, Psy.D, Central Rater Manager, Cogstate
Dr. Mikako Moriyasu is a Central Rater manager at Cogstate with background in the assessment of in neurodegenerative disorders. She is skilled in Autism Spectrum Disorders, ADHD, Sensory Processing Therapy, Cognitive Behavioral Therapy and Memory Improvement Group sessions for MCI. She has strong research background, with a PsyD focused in Clinical Psychology from California School of Professional Psychology at Alliant International University, San Francisco.
Message Presenter
Wen-Yu Cheng, Psy.D, Licensed Neuropsychologist, Psychologist, and Jungian Analyst
Dr. Wen-Yu Cheng is a licensed psychologist, Jungian analyst, and neuropsychologist, holding practice licenses in Washington State and through PSYPACT for cross-state teletherapy. He earned his doctorate in clinical psychology from the Wright Institute in California, completed a predoctoral internship at Mount Sinai Medical Center in New York City, and a postdoctoral fellowship in clinical neuropsychology at Barrow Neurological Institute in Phoenix, AZ. Following his fellowship, he worked as a faculty neuropsychologist at Barrow, specializing in treating patients with acquired brain injuries. Dr. Cheng pursued advanced studies in analytical psychology as an international scholar and fellow at the C.G. Jung Institute of San Francisco. He is also a certified MBTI practitioner and Hakomi therapist.
Dr. Cheng’s practice focuses on bilingual (English and Mandarin) Jungian psychotherapy, neuropsychological evaluations, and neurorehabilitation. He regularly leads seminars that integrate Buddhist perspectives, somatic mindfulness-based interventions, neuropsychology, and analytical psychology. Dr. Cheng serves as a board member of the C.G. Jung Institute of San Francisco and has worked as a neuropsychology consultant for global studies in China and Taiwan with Cogstate Inc.
Message PresenterWho Should Attend?
Executives, directors, scientists and managers from pharma, biotech and CROs responsible for global CNS clinical trials, including:
- Research and Development
- Clinical Operations
- Clinical Science
- Outcomes Research
- Outsourcing and Procurement
- Project Management
- Clinical Trial Planning and Optimization
- Medical Affairs
What You Will Learn
Attendees will be introduced to:
- Key factors driving the regional growth of clinical trials in the Asia-Pacific (APAC) region
- Regional nuances impacting central nervous system (CNS) assessment
- Ways to address regional challenges in cognitive measurement, rater training, decentralized trials and operational delivery
Xtalks Partner
Cogstate
Cogstate Ltd (ASX:CGS) is a leading science and technology solutions provider dedicated to optimizing the measurement of cognition in clinical trials, academic research and healthcare. Cogstate provides enabling technologies and professional services for higher quality neuropsychological assessments and is a pioneer in commercializing rapid, reliable and highly sensitive computerized cognitive tests. Cogstate customers include the world’s leading biopharmaceutical companies; elite sporting organizations and military; physicians and patients; renowned academic institutions and public-private partnerships. For more information, please visit www.cogstate.com.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account